Free Trial

Feedback Interim Earnings Report

Feedback logo
GBX 16.85 -0.05 (-0.30%)
As of 04/1/2025 07:16 AM Eastern

Feedback EPS Results

Actual EPS
-GBX 14.22
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Feedback Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Feedback Announcement Details

Quarter
Interim
Time
Before Market Opens

Conference Call Resources

Remove Ads

Feedback Earnings Headlines

Vicat Q3 2024 Sales
Crypto Genius: 12,000% in 12 months? [Here’s how]
We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.
See More Feedback Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Feedback? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Feedback and other key companies, straight to your email.

About Feedback

Feedback (LON:FDBK) (AIM: FDBK) provides innovative software and systems through its trading subsidiary, Feedback Medical. Feedback liberates data and knowledge from multiple healthcare IT systems and delivers better workflows to enable clinicians to communicate, collaborate and provide the best healthcare for their patients. It connects care settings with diagnostic and other relevant data to drive better, faster, safer decision that improve outcomes for patients. By linking different clinical systems together into a seamless view of the patient, Feedback can streamline patient pathways and deliver a digital health and diagnostics record across multiple care providers. Bleepa® is a communication and collaboration platform that displays clinical results at a certified and regulated quality, which enables multi-disciplinary team working and diagnostic-enhanced advice and guidance. CareLocker® is a patient-facing platform that gives patients access and control over their diagnostic and other clinical data. The Company has a number of growth opportunities domestically and internationally across a range of public and private healthcare markets including the NHS. Our highly scalable software-as-a-service (SaaS) based model is expected to provide increasing levels of revenue visibility as the Company grows its customer base.

View Feedback Profile

More Earnings Resources from MarketBeat